CIK 0001850902 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Alpha Teknova, Inc.
Sign in to watch- Ticker
- TKNO
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943368109
- Phone
- 8316371100
- Business address
- 2451 BERT DRIVE, HOLLISTER, CA, 95023
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-06-02 | ROBERTSON BRETT Director | Grant or award | +9,357 | 9,357 | ||
| 2022-06-02 | McNamara Robert Director | Grant or award | +9,357 | 9,357 | ||
| 2022-05-20 | Lowell Matthew Chief Financial Officer | Purchase | +10,000 | $9.45 | $94K | 10,000 |
| 2022-05-13 | Hood Lisa Chief People Officer | Purchase | +772 | $10.93 | $8K | 31,234 |
| 2022-05-13 | Gunstream Stephen President and CEO | Purchase | +1,292 | $10.93 | $14K | 1,292 |
| 2022-02-15 | Terrill Damon General Counsel and CCO | Grant or award · Non-Qualified Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2022-02-15 | Lowell Matthew Chief Financial Officer | Grant or award · Non-Qualified Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2022-02-15 | Hood Lisa Chief People Officer | Grant or award · Non-Qualified Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2022-02-15 | Gunstream Stephen President and CEO | Grant or award · Non-Qualified Stock Option (right to buy) | +175,000 | 175,000 | ||
| 2022-02-15 | Gelhaus Ken Chief Commercial Officer | Grant or award · Non-Qualified Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2022-02-04 | Hood Lisa Chief People Officer | Option exercise | +30,462 | $1.85 | $56K | 30,462 |
| 2022-02-04 | Hood Lisa Chief People Officer | Option exercise · Incentive Stock Option (right to buy) | −30,462 | 82,014 | ||
| 2021-11-17 | Gelhaus Ken Chief Commercial Officer | Grant or award · Stock Option (Right to buy) | +85,000 | 85,000 | ||
| 2021-11-17 | Gelhaus Ken Chief Commercial Officer | Grant or award · Stock Option (Right to buy) | +85,000 | 85,000 | ||
| 2021-09-15 | Davis Ted Director | Purchase | +1,429 | $27.08 | $39K | 1,886,419 |
| 2021-09-08 | Davis Ted Director | Purchase | +1,300 | $22.61 | $29K | 1,884,990 |
| 2021-08-25 | Davis Ted Director | Purchase | +9,090 | $19.95 | $181K | 1,883,690 |
| 2021-06-28 | Telegraph Hill Partners IV, L.P. 10% owner | Conversion | +14,941,823 | 14,941,823 | ||
| 2021-06-28 | Telegraph Hill Partners IV, L.P. 10% owner | Conversion | +2,570,862 | 2,570,862 | ||
| 2021-06-28 | Telegraph Hill Partners IV, L.P. 10% owner | Conversion · Series A Convertible Preferred Stock | −7,970,673 | 0 |
Page 5 of 6 · 106 trades